John F. Pearson

Survival of myeloma patients following the introduction of thalidomide as a second‐line therapy: a retrospective study at a single New Zealand centre

P. Ganly, B. Hock, J. Pearson, 2013, Internal medicine journal.

Levels and in vitro functional effects of circulating anti-hinge antibodies in melanoma patients receiving the immune checkpoint inhibitor pembrolizumab

Liping Goddard, S. MacPherson, Barry D Hock, 2023, PloS one.